IL109151A - Medicinal preparations for the treatment of skin diseases - Google Patents

Medicinal preparations for the treatment of skin diseases

Info

Publication number
IL109151A
IL109151A IL10915194A IL10915194A IL109151A IL 109151 A IL109151 A IL 109151A IL 10915194 A IL10915194 A IL 10915194A IL 10915194 A IL10915194 A IL 10915194A IL 109151 A IL109151 A IL 109151A
Authority
IL
Israel
Prior art keywords
psoriasis
composition
dermatitis
denotes
compound
Prior art date
Application number
IL10915194A
Other languages
English (en)
Hebrew (he)
Other versions
IL109151A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21915403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL109151(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL109151A0 publication Critical patent/IL109151A0/xx
Publication of IL109151A publication Critical patent/IL109151A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL10915194A 1993-03-31 1994-03-29 Medicinal preparations for the treatment of skin diseases IL109151A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4122393A 1993-03-31 1993-03-31

Publications (2)

Publication Number Publication Date
IL109151A0 IL109151A0 (en) 1994-06-24
IL109151A true IL109151A (en) 1998-12-27

Family

ID=21915403

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10915194A IL109151A (en) 1993-03-31 1994-03-29 Medicinal preparations for the treatment of skin diseases

Country Status (17)

Country Link
US (1) US5504084A (fr)
EP (1) EP0617959B1 (fr)
JP (1) JP2930281B2 (fr)
KR (1) KR100310665B1 (fr)
AT (1) ATE183088T1 (fr)
AU (1) AU670491B2 (fr)
CA (1) CA2120319C (fr)
CY (1) CY2207B1 (fr)
DE (1) DE69419954T2 (fr)
DK (1) DK0617959T3 (fr)
ES (1) ES2135500T3 (fr)
GR (1) GR3031264T3 (fr)
HU (1) HU216194B (fr)
IL (1) IL109151A (fr)
RU (1) RU2151597C1 (fr)
TW (1) TW314467B (fr)
ZA (1) ZA942257B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814649A (en) * 1994-10-17 1998-09-29 Hoechst Pharmaceuticals & Chemicals K.K. Preventive and remedy for type 1 allergic diseases
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
ATE207065T1 (de) * 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
EP1935416A3 (fr) 2001-04-05 2008-10-22 Aventis Pharma Inc Utilisation de l'acide (Z)-2-cyano-3-hydroxy-but-2-enoïque-(4'-trifluorromethylphenyl)-amide pour traiter la sclérose en plaques
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
JPWO2005011669A1 (ja) * 2003-08-05 2006-09-14 大日本住友製薬株式会社 経皮投与用医薬組成物
CA2571710A1 (fr) 2004-06-24 2006-11-02 Nicholas Valiante Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
EP1844778A4 (fr) * 2005-02-02 2010-11-03 Kowa Co Agent pour la prévention/thérapie d'une maladie provoquée par le développement de kératinocytes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3035670A1 (de) * 1980-09-22 1982-04-29 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zur infusion von fluessigkeiten in den menschlichen oder tierischen koerper
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DE3927257A1 (de) * 1989-08-18 1991-02-21 Hoechst Ag Verfahren zur herstellung eines polyolefins
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DK0527736T3 (da) * 1990-05-18 1997-10-20 Hoechst Ag Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler.
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
DE4227594A1 (de) * 1992-08-20 1994-02-24 Wacker Chemie Gmbh Synthetische Alumosilikate und ihre Verwendung als heterogene Äquilibrierungskatalysatoren

Also Published As

Publication number Publication date
HU9400908D0 (en) 1994-06-28
AU670491B2 (en) 1996-07-18
IL109151A0 (en) 1994-06-24
US5504084A (en) 1996-04-02
ZA942257B (en) 1994-11-16
DE69419954T2 (de) 2000-04-13
DE69419954D1 (de) 1999-09-16
ATE183088T1 (de) 1999-08-15
GR3031264T3 (en) 1999-12-31
KR940021060A (ko) 1994-10-17
JP2930281B2 (ja) 1999-08-03
HUT70757A (en) 1995-10-30
ES2135500T3 (es) 1999-11-01
CY2207B1 (en) 2002-11-08
AU5915794A (en) 1994-10-06
DK0617959T3 (da) 2000-01-24
CA2120319C (fr) 2009-01-06
HU216194B (hu) 1999-05-28
EP0617959A1 (fr) 1994-10-05
RU2151597C1 (ru) 2000-06-27
JPH06329538A (ja) 1994-11-29
TW314467B (fr) 1997-09-01
AU670491C (en) 1994-10-06
EP0617959B1 (fr) 1999-08-11
CA2120319A1 (fr) 1994-10-01
KR100310665B1 (ko) 2001-12-28

Similar Documents

Publication Publication Date Title
US5519042A (en) Method of treating hyperproliferative vascular disease
EP0236684B1 (fr) Galanthamine ou ses analogues pour le traitement de la maladie d'Alzheimer
US6251927B1 (en) Methods for treatment of sickle cell anemia
US5344829A (en) Use of OB-101 to treat inflammation
US5504084A (en) Pharmaceutical for the treatment of skin disorders
US4861783A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US5198454A (en) Use of OB-104 to treat ocular inflammation
CN111635315B (zh) 一种解热镇痛药物及其制备方法和用途
MXPA06011823A (es) Terapia de combinacion, que comprende un antagonista del receptor de la adenosina a1 y un inhibidor de la aldosterona.
EP0780125B1 (fr) Utilisation de dérivés d'hydantoine pour la préparation d'un médicament pour le traitement des maladies associées à la présence d'oxygène actif et de radicaux libres
JPH0372463A (ja) 腎機能改善剤
US5266595A (en) Method for treatment of cystinuria
JPS6388137A (ja) 非ステロイド系抗炎症剤を含む医薬製剤
JPH0952831A (ja) 急性腎不全治療・予防剤
JP2000264849A (ja) 頻尿・尿失禁治療組成物
US20180303802A1 (en) Methods for treating synovial sarcoma
CN112512526B (zh) 化合物a与化合物b联合在制备治疗痛风或高尿酸血症的药物中的用途
WO2002011721A1 (fr) Composition pharmaceutique comprenant de la metformine et un derive de type 5-phenoxyalkyle-2,4-thiazolidinedione
JPS61129124A (ja) 抗腫瘍剤
US3622671A (en) Substituted 3-hydrazino pyridazines as hypotensives
CA1296639C (fr) Agents pour le traitement de maladies renales
JPH10330265A (ja) 肝疾患治療剤
CN117425477A (zh) 包含1-(3-氰基-1-异丙基-吲哚-5-基)吡唑-4-甲酸的药物组合物
ITRM940625A1 (it) Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico
WO1992004894A1 (fr) Antirhumatismal

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired